Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Podcasts

Episode 2: BTK Inhibitors for CLL and Lymphomas

Leonard/FurmanOn this episode of Blood Bytes, a hematology podcast produced by Oncology Learning Network, John Leonard, MD, Senior Associate Dean and Professor of Hematology/Oncology at Weill Cornell Medicine and NewYork-Presbyterian Hospital, and Richard Furman, MD, Distinguished Associate Professor of Medicine and Director of CLL Research at Weill Cornell Medicine, discuss BTK inhibitors for the treatment of CLL and lymphomas.

 

Advertisement

Advertisement

Advertisement

Advertisement